Angela Nordquist
Family · Pleasant View, TNNPI 1720459241
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 264 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by Novo Nordisk at 26.7% of the total. Among family clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 264 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$497
- AbbVie$440
- Abbott$256
- AstraZeneca$231
- Otsuka America Pharmaceutical, Inc.$219
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,744100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 71 | $1,265 |
| Lilly USA, LLC | 32 | $497 |
| AbbVie | 23 | $440 |
| Abbott | 13 | $256 |
| AstraZeneca | 15 | $231 |
| Otsuka America Pharmaceutical, Inc. | 11 | $219 |
| Novartis | 9 | $204 |
| Johnson & Johnson | 10 | $182 |
| Boehringer Ingelheim | 9 | $154 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $151 |
| Esperion Therapeutics, Inc. | 11 | $141 |
| GSK | 7 | $124 |
| Pfizer | 5 | $102 |
| Bayer | 5 | $84 |
| Merck | 5 | $84 |
| Dexcom, Inc. | 2 | $64 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $63 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $61 |
| Xeris Pharmaceuticals, Inc. | 3 | $60 |
| Sanofi-aventis U.S. LLC | 3 | $48 |
| Corcept Therapeutics | 1 | $40 |
| Amgen | 2 | $39 |
| Shield Therapeutics Inc | 2 | $37 |
| Amarin Pharma, Inc. | 2 | $36 |
| Sanofi | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Currax Pharmaceuticals LLC | 2 | $25 |
| Alfasigma USA, Inc. | 1 | $20 |
| Acadia Pharmaceuticals Inc | 1 | $19 |
| Mylan Specialty L.p. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$4,744 in reported general payments places this provider in the 90th percentile of 6,706 family providers in Tennessee.
Other family in Pleasant View
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
- Laura PorchCordova$148K
- Lori LankfordNashville$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.